Fortis Healthcare Reports Strong Financial Performance in Q1 FY25, Poised for Growth

Fortis Healthcare, a leading healthcare services company, has recently announced its financial results for the quarter ended June 2024. The company has shown positive performance in this quarter, with a score of 14 compared to 18 in the previous quarter.

One of the key highlights of the financials is the growth in Profit After Tax (PAT) for the half-yearly period, which has increased by 45.43% year on year. This is a significant improvement and the near-term trend for PAT looks very positive.

Another positive aspect is the Inventory Turnover Ratio, which has been consistently growing in the last five half-yearly periods. This indicates that the company has been able to sell its inventory at a faster rate.

Fortis Healthcare has also generated a high Operating Cash Flow of Rs 1,100.10 crore annually in the last three years. This shows that the company has been able to generate higher cash revenues from its business operations.

In terms of sales, the company has achieved its highest quarterly net sales of Rs 1,858.90 crore in the last five quarters. This indicates a positive trend in the near term.

Fortis Healthcare also has a strong cash position, with the highest cash and cash equivalents of Rs 598.40 crore in the last six half-yearly periods. This shows an improvement in short-term liquidity.

Lastly, the company has been consistently distributing higher dividends to its shareholders, with the highest dividend per share of Rs 1.00 in the last five years. This is a positive sign for investors.

Based on these financials, MarketsMOJO has given a ‘Hold’ call for Fortis Healthcare’s stock. With its strong financial performance and positive trends, the company is poised for growth in the healthcare services industry.